Design and evaluation of oral nanoemulsion drug delivery system of mebudipine

Drug Delivery

Volumn 23, Issue 6, 2016, Pages 2035-2043

  Khani, Samira ^a   Keyhanfar, Fariborz ^b   Amani, Amir ^c,d  

^a QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioavailability; mebudipine; nanoemulsion

Indexed keywords

ALCOHOL; CALCIUM CHANNEL BLOCKING AGENT; DEIONIZED WATER; MACROGOL 400; MEBUDIPINE; OLEIC ACID ETHYL ESTER; POLYSORBATE 80; SORBITAN OLEATE; UNCLASSIFIED DRUG; DRUG CARRIER; EMULSION; NANOPARTICLE; NIFEDIPINE; POLYSORBATE; SOLUTION AND SOLUBILITY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG STABILITY; MALE; MORPHOLOGY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SONICATOR; SUSPENSION; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CHEMISTRY; EMULSION; MEDICINAL CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; SOLUBILITY; SOLUTION AND SOLUBILITY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; NANOPARTICLES; NIFEDIPINE; POLYSORBATES; RATS; SOLUBILITY; SOLUTIONS;

EID: 84945217069     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1088597     Document Type: Article

References (43)

1. A.Azeem, M.Rizwan, F.J.Ahmad,. (2009). Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69–76
2. V.Bali, M.Ali, J.Ali. (2010). Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Coll Surf B Biointerfaces 76:410–20
3. S.Bohlooli, F.Keyhanfar, M.Mahmoudian. (2004a). Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats. Biopharm Drug Dispos 25:187–91
4. S.Bohlooli, M.Mahmoudian, G.Skellern,. (2004b). Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes. J Pharm Pharmacol 56:1469–74
5. R.C.Bravo Gonzalez, J.Huwyler, F.Boess,. (2004). In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharm Drug Dispos 25:37–49
6. G.Chhabra, K.Chuttani, A.K.Mishra, K.Pathak. (2011a). Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm 37:907–16
7. H.-G.Choi, D.-D.Kim, H.Won Jun,. (2003). Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 29:1085–94
8. Y.A.Choi, Y.H.Yoon, K.Choi,. (2015). Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats. Biol Pharmaceut Bull 38:208–17
9. S.Debnath, D.Satayanarayana, G.Vijay Kumar. (2011). Nanoemulsion-A method to improve the solubility of lipophilic drugs. Pharmanest 2:72–83
10. M.A.Elsheikh, Y.S.Elnaggar, E.Y.Gohar, O.Y.Abdallah. (2012). Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine 7:3787–802
11. M.Faizi, M.Janahmadi, M.Mahmoudian. (2003). The effect of mebudipine and dibudipine, two new Ca 2+ channel blockers, in comparison with nifedipine on Ca 2+ spikes of F 1 neuronal soma membrane in Helix aspersa. Acta Physiol Hungarica 90:243–54
12. G.Fricker, T.Kromp, A.Wendel,. (2010). Phospholipids and lipid-based formulations in oral drug delivery. Pharmaceut Res 27:1469–86
13. R.Gannu, C.R.Palem, V.V.Yamsani,. (2010). Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization ex vivo and in vivo characterization. Int J Pharm 388:231–41
14. Z.-G.Gao, H.-G.Choi, H.-J.Shin,. (1998). Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm 161:75–86
15. T.Gershanik, S.Benita. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 50:179–88
16. B.Gorain, H.Choudhury, A.Kundu,. (2014). Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Coll Surf B Bioint 115:286–94
17. M.Han, C.X.He, Q.L.Fang,. (2009). A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm Res 26:926–35
18. J.Hecq, G.Nollevaux, M.Deleers,. (2006). Nifedipine nanocrystals: pharmacokinetic evaluation in the rat and permeability studies in Caco-2/HT29–5M21 (co)-cultures. J Drug Deliv Sci Technol 16:437
19. M.A.Hedaya. (2012). Basic pharmacokinetics. London: Taylor & Francis
20. E.D.Hugger, B.L.Novak, P.S.Burton,. (2002). A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J Pharm Sci 91:1991–2002
21. P.Izquierdo, J.Esquena, T.F.Tadros,. (2002). Formation and stability of nano-emulsions prepared using the phase inversion temperature method. Langmuir 18:26–30
22. A.A.Kale, V.B.Patravale. (2008). Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech 9:191–6
23. F.Keyhanfar, S.Khani, S.Bohlooli. (2014). Evaluation of lipid-based drug delivery system (Phytosolve) on oral bioavailability of dibudipine. Iran J Pharm Res 13:1149--1156
24. S.Khani, F.Keyhanfar. (2014). Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF). AAPS PharmSciTech 15:96–102
25. C.-K.Kim, Y.-J.Cho, Z.-G.Gao. (2001). Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J Control Rel 70:149–55
26. S.Kotta, A.W.Khan, S.Ansari,. (2013). Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv 22:455–466
27. M.J.Lawrence, G.D.Rees. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
28. Z.H.Luo, X.L.Zhan, P.Y.Yu. (2004). Effect of addition of cosurfactant on the phase behaviour of oil-in-water aminosilicone oil microemulsion. Chinese Chem Lett 15:1101–4
29. M.Mahmoudian, H.Mirkhani, Z.Nehardani, S.Ghiaee. (1997). Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine. J Pharm Pharmacol 49:1229–33
30. R.Neslihan Gursoy, S.Benita. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–82
31. V.Polychniatou, C.Tzia. (2014). Study of formulation and stability of co-surfactant free water-in-olive oil nano-and submicron emulsions with food grade non-ionic surfactants. J Am Oil Chem Soc 91:79–88
32. Salager JL, Anderez JM, Briceno MI, et al. (2002). Emulsification yield related to formulation and composition variables as well as stirring energy. Revista Tecnica de la Facultad de Ingenieria Universidad del Zulia 25:129--39
33. L.Sepehr-Ara, S.A.Mohajeri, M.Mahmoudian. (2011). Effect of the two new calcium channel blockers mebudipine and dibudipine on vascular flow of isolated kidney of normal and diabetic rats. Pathophysiology 18:175–84
34. S.Shafiq, F.Shakeel, S.Talegaonkar,. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66:227–43
35. S.Shafiq-Un-Nabi, F.Shakeel, S.Talegaonkar,. (2007). Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 8. doi: 10.1208/pt0802028
36. S.Sharma, J.K.Sahni, J.Ali, S.Baboota. (2014). Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin-pharmacodynamic and antioxidant studies. Drug Deliv 22:541–551
37. Q.Shen, Y.Wang, Y.Zhang. (2011). Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer. Int J Nanomedicine 6:1237–43
38. M.Stuchlik, S.Zak. (2001). Lipid-based vehicle for oral drug delivery. Biomed Pap Med Fac Univ Palacky Olomouc 145:17–26
39. K.Thrivikraman, R.L.Huot, P.M.Plotsky. (2002). Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. Brain Res Protocols 10:84–94
40. S.Vatsraj, K.Chauhan, H.Pathak. (2014). Formulation of a novel nanoemulsion system for enhanced solubility of a sparingly water soluble antibiotic, clarithromycin. J Nanosci 1–7 doi: http://dx.doi.org/10.1155/2014/268293
41. P.R.Veerareddy, K.Poluri, R.Sistla,. (2012). Formulation development and comparative pharmacokinetic evaluation of felodipine nanoemulsion in SD rats. Am J PharmTech Res 2:931–45
42. P.Verma, J.G.Meher, S.Asthana,. (2014). Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Drug Deliv 1–10 doi: http://dx.doi.org/10.3109/10717544.2014.920430
43. J.Xi, Q.Chang, C.K.Chan,. (2009). Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 10:172–82